SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
21-Jun-24 5:11 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 21-Jun-24 | Grant | 41,581 | -- | -- | 87% 47.97K to 89.55K | |
13-Sep-23 4:11 PM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 11-Sep-23 | Sale (Planned) | 5,000 | $25.05 | $125,238.00 | (9%) 52.97K to 47.97K | |
12-Sep-22 7:07 AM View: | Zentalis Pharmaceuticals, I... (ZNTL) | 09-Sep-22 | Grant | 36,606 | -- | -- | 100% 0 to 36.61K | |
13-May-21 4:12 PM View: | Trillium Therapeutics Inc. (TRIL) | 12-May-21 | Option Exercise | 23,802 | $0.31 | $7,473.83 | 100% 0 to 23.8K | |
13-May-21 4:12 PM View: | Trillium Therapeutics Inc. (TRIL) | 12-May-21 | Market Option Sale | 23,802 | $9.24 | $219,880.00 | (100%) 23.8K to 0 | 13% |
13-May-21 4:12 PM View: | Trillium Therapeutics Inc. (TRIL) | 11-May-21 | Option Exercise | 106,698 | $0.42 | $45,070.70 | 100% 0 to 106.7K | |
13-May-21 4:12 PM View: | Trillium Therapeutics Inc. (TRIL) | 11-May-21 | Market Option Sale | 106,698 | $9.20 | $981,803.00 | (100%) 106.7K to 0 | 13% |
15-Jan-21 4:19 PM View: | Trillium Therapeutics Inc. (TRIL) | 14-Jan-21 | Option Exercise | 19,581 | $0.43 | $8,370.88 | 100% 0 to 19.58K | |
15-Jan-21 4:19 PM View: | Trillium Therapeutics Inc. (TRIL) | 14-Jan-21 | Market Option Sale (Planned) | 19,581 | $15.03 | $294,279.00 | (100%) 19.58K to 0 | 47% |
15-Jan-21 4:19 PM View: | Trillium Therapeutics Inc. (TRIL) | 13-Jan-21 | Option Exercise | 5,419 | $0.42 | $2,301.99 | 100% 0 to 5.42K | |
15-Jan-21 4:19 PM View: | Trillium Therapeutics Inc. (TRIL) | 13-Jan-21 | Market Option Sale (Planned) | 5,419 | $15.04 | $81,507.70 | (100%) 5.42K to 0 | 47% |